A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...
Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer ...
Experimental gene therapies like AMT‑130 lower toxic huntingtin protein and significantly slow Huntington’s disease, offering ...
Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...
New study shows that cancer damages its own DNA by pushing key genes to work too hard. Researchers found that the most ...
Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...
Alcohol can harm more than your liver and heart—new insights reveal it damages DNA, increasing cancer risk. Experts explain ...
Junior research group leader Dr. Anne Fassl from the Department of Urology at Universitätsmedizin Frankfurt has been awarded a Young Investigator Award 2025 by the U.S.-based Prostate Cancer ...
Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, ​the Germany-based startup said on ...
On behalf of Lilly, Seamless will design and programme recombinases that can correct alterations in multiple genes involved ...
Antal and Yeo, who also are members of UCSD’s Moores Cancer Center, say the key to targeting triple-negative breast cancer, or TNBC, is managing a protein called poly (U)-binding splicing factor 60, ...